Celluris is the first Latin America company developing personalized treatment for cancer patients through CAR-T immunotherapy. The therapy is based on the modification of the patient’s own cells that now can precisely recognize and kill tumoral cells.
Business Model: B2C for cancer patients
Product: In development
Want more information?
Email: [email protected]